| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors.
|
J Nucl Med
|
2012
|
1.31
|
|
2
|
68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors.
|
J Nucl Med
|
2010
|
1.26
|
|
3
|
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT.
|
Radiology
|
2013
|
1.22
|
|
4
|
Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.
|
Eur J Nucl Med Mol Imaging
|
2009
|
1.18
|
|
5
|
para-Functionalized aryl-di-tert-butylfluorosilanes as potential labeling synthons for (18)F radiopharmaceuticals.
|
Chemistry
|
2009
|
1.18
|
|
6
|
18F-labeling of peptides by means of an organosilicon-based fluoride acceptor.
|
Angew Chem Int Ed Engl
|
2006
|
1.13
|
|
7
|
A universally applicable 68Ga-labeling technique for proteins.
|
J Nucl Med
|
2011
|
1.10
|
|
8
|
Silica- and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging.
|
Langmuir
|
2007
|
1.03
|
|
9
|
Synthesis of p-(di-tert-butyl[(18)F]fluorosilyl)benzaldehyde ([(18)F]SiFA-A) with high specific activity by isotopic exchange: a convenient labeling synthon for the (18)F-labeling of N-amino-oxy derivatized peptides.
|
Bioconjug Chem
|
2007
|
1.03
|
|
10
|
(89)Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges.
|
Molecules
|
2013
|
1.01
|
|
11
|
One-step (18)F-labeling of peptides for positron emission tomography imaging using the SiFA methodology.
|
Nat Protoc
|
2012
|
1.00
|
|
12
|
Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
|
J Nucl Med
|
2013
|
0.98
|
|
13
|
Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.94
|
|
14
|
Synthesis of [(18)F]SiFB: a prosthetic group for direct protein radiolabeling for application in positron emission tomography.
|
Nat Protoc
|
2012
|
0.92
|
|
15
|
Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors.
|
J Nucl Med
|
2011
|
0.90
|
|
16
|
The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes.
|
J Nucl Med
|
2010
|
0.87
|
|
17
|
One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET).
|
Bioconjug Chem
|
2010
|
0.87
|
|
18
|
Endogenous competition against binding of [(18)F]DMFP and [(18)F]fallypride to dopamine D(2/3) receptors in brain of living mouse.
|
Synapse
|
2010
|
0.85
|
|
19
|
Microfluidics: a groundbreaking technology for PET tracer production?
|
Molecules
|
2013
|
0.85
|
|
20
|
Synthesis of 3-chloro-6-((4-(di-tert-butyl[(18)F]fluorosilyl)-benzyl)oxy)-1,2,4,5-tetrazine ([(18)F]SiFA-OTz) for rapid tetrazine-based (18)F-radiolabeling.
|
Chem Commun (Camb)
|
2015
|
0.85
|
|
21
|
Validation of the octamouse for simultaneous 18F-fallypride small-animal PET recordings from 8 mice.
|
J Nucl Med
|
2010
|
0.85
|
|
22
|
[18F]SiFA-isothiocyanate: a new highly effective radioactive labeling agent for lysine-containing proteins.
|
Chembiochem
|
2009
|
0.84
|
|
23
|
Evaluation of an automated double-synthesis module: efficiency and reliability of subsequent radiosyntheses of FHBG and FLT.
|
Nucl Med Biol
|
2011
|
0.83
|
|
24
|
[18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
|
Addict Biol
|
2011
|
0.83
|
|
25
|
Uptake and binding of the serotonin 5-HT1A antagonist [18F]-MPPF in brain of rats: effects of the novel P-glycoprotein inhibitor tariquidar.
|
Neuroimage
|
2009
|
0.82
|
|
26
|
Multimerization of cRGD peptides by click chemistry: synthetic strategies, chemical limitations, and influence on biological properties.
|
Chembiochem
|
2010
|
0.82
|
|
27
|
Synthesis and in vitro and in vivo evaluation of SiFA-tagged bombesin and RGD peptides as tumor imaging probes for positron emission tomography.
|
Bioconjug Chem
|
2014
|
0.81
|
|
28
|
Radiolabeled heterobivalent peptidic ligands: an approach with high future potential for in vivo imaging and therapy of malignant diseases.
|
ChemMedChem
|
2013
|
0.80
|
|
29
|
Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy.
|
Epilepsia
|
2010
|
0.79
|
|
30
|
t-Bu2SiF-derivatized D2-receptor ligands: the first SiFA-containing small molecule radiotracers for target-specific PET-imaging.
|
Molecules
|
2011
|
0.78
|
|
31
|
Compensation for cranial spill-in into the cerebellum improves quantitation of striatal dopamine D₂/₃ receptors in rats with prolonged [¹⁸F]-DMFP infusions.
|
Synapse
|
2012
|
0.78
|
|
32
|
DOTA derivatives for site-specific biomolecule-modification via click chemistry: synthesis and comparison of reaction characteristics.
|
Bioorg Med Chem
|
2010
|
0.78
|
|
33
|
From Unorthodox to Established: The Current Status of (18)F-Trifluoroborate- and (18)F-SiFA-Based Radiopharmaceuticals in PET Nuclear Imaging.
|
Bioconjug Chem
|
2015
|
0.77
|
|
34
|
Perspectives of novel imaging techniques for staging, therapy response assessment, and monitoring of surveillance in lung cancer: summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop.
|
J Thorac Oncol
|
2015
|
0.77
|
|
35
|
Simple and convenient radiolabeling of proteins using a prelabeling-approach with thiol-DOTA.
|
Bioorg Med Chem Lett
|
2009
|
0.77
|
|
36
|
Comparison between 68Ga-bombesin (68Ga-BZH3) and the cRGD tetramer 68Ga-RGD4 studies in an experimental nude rat model with a neuroendocrine pancreatic tumor cell line.
|
EJNMMI Res
|
2011
|
0.76
|
|
37
|
A solvent resistant lab-on-chip platform for radiochemistry applications.
|
Lab Chip
|
2014
|
0.76
|
|
38
|
Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging?
|
Future Med Chem
|
2013
|
0.75
|
|
39
|
(99m)Tc complexes with activated ester functions; ligands comprising a 3,4-diamino-benzoate backbone.
|
Nucl Med Biol
|
2006
|
0.75
|
|
40
|
From molecular imaging markers to personalized image-guided therapy.
|
Z Med Phys
|
2013
|
0.75
|
|
41
|
Radiofluorinated N-Octanoyl Dopamine ([(18)F]F-NOD) as a Tool To Study Tissue Distribution and Elimination of NOD in Vitro and in Vivo.
|
J Med Chem
|
2016
|
0.75
|
|
42
|
Fully automated SPE-based synthesis and purification of 2-[18F]fluoroethyl-choline for human use.
|
Nucl Med Biol
|
2010
|
0.75
|
|
43
|
Direct one-step labeling of cysteine residues on peptides with [(11)C]methyl triflate for the synthesis of PET radiopharmaceuticals.
|
Amino Acids
|
2013
|
0.75
|
|
44
|
In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.
|
Mol Imaging Biol
|
2011
|
0.75
|
|
45
|
PESIN multimerization improves receptor avidities and in vivo tumor targeting properties to GRPR-overexpressing tumors.
|
Bioconjug Chem
|
2014
|
0.75
|
|
46
|
Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding?
|
J Med Chem
|
2014
|
0.75
|
|
47
|
Dose-dependent uptake of 3'-deoxy-3'-[(18) F]fluorothymidine by the bowel after total-body irradiation.
|
Mol Imaging Biol
|
2014
|
0.75
|
|
48
|
α2-adrenergic drugs modulate the binding of [18F]fallypride to dopamine D2/3 receptors in striatum of living mouse.
|
Synapse
|
2010
|
0.75
|